Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

AACR 2009

18 - 22 Apr 2009
Activating p53 and cell senescence to regress tumours
Dr Karen Vousden - Beatson Institute for Cancer Research, Glasgow
Activating p53 and cell senescence to regress tumours ( Dr Karen Vousden - Beatson Institute for Cancer Research, Glasgow )
8 Jul 2009
Genetic determinants for breast cancer spread
Dr Kent Hunter - National Cancer Institute, Bethesda, USA
Genetic determinants for breast cancer spread ( Dr Kent Hunter - National Cancer Institute, Bethesda, USA )
8 Jul 2009
Mouse models to ID genetic controls and 3D models to help personalise therapy
Dr Marco Pieroti - National Cancer Institute, Milan, Italy
Mouse models to ID genetic controls and 3D models to help personalise therapy ( Dr Marco Pieroti - National Cancer Institute, Milan, Italy )
8 Jul 2009
Selecting appropriate first line lung cancer therapy
Dr Paul Bunn - University of Colorado, Denver, USA
Selecting appropriate first line lung cancer therapy ( Dr Paul Bunn - University of Colorado, Denver, USA )
8 Jul 2009
Studying genetics behind drug resistance using cell culture models
Dr René Bernards - Netherlands Cancer Institute, Amsterdam
Studying genetics behind drug resistance using cell culture models ( Dr René Bernards  - Netherlands Cancer Institute, Amsterdam )
8 Jul 2009
MicroRNAs regulating cancer stem cell self renewal
Dr Michael Clarke - Stanford School of Medicine, USA
MicroRNAs regulating cancer stem cell self renewal ( Dr Michael Clarke - Stanford School of Medicine, USA )
8 Jul 2009
Study of the extra cellular matrix around cancer cells and 3D assays
Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA
Study of the extra cellular matrix around cancer cells and 3D assays ( Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA )
8 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast c...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer ( Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US )
3 Jul 2009
AACR 2009: Circulating tumour cells as biomarkers
Dr Howard Scher - Sloan Kettering Memorial Cancer Center
AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )
5 Jun 2009
AACR 2009: Tackling the p53 gene and side effects
Professor David Lane - Director of the Cancer Research UK Transformation Researc...
AACR 2009: Tackling the p53 gene and side effects ( Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee )
18 May 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009
AACR 2009: Chemokine inhibitors to prevent tumour growth
Prof Alberto Mantovani - Professor of General Pathology, University of Milan
AACR 2009: Chemokine inhibitors to prevent tumour growth ( Prof Alberto Mantovani - Professor of General Pathology, University of Milan )
14 May 2009
AACR 2009: Cancer stem cells and leukaemia
Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School ...
AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours
Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009
AACR 2009: Caucasian-american and african-american breast cancer risk factors
Prof Yong Cui - Department of Internal Medicine, Meharry Medical College, USA
AACR 2009: Caucasian-american and african-american breast cancer risk factors ( Prof Yong Cui - Department of Internal Medicine, Meharry Medical College, USA )
7 May 2009
AACR 2009: Enhancement of recruitment of african-americans to cancer trials
Dr Debra Wujcik - Director of Cancer Clinical Trials, Meharry Medical College / ...
AACR 2009: Enhancement of recruitment of african-americans to cancer trials ( Dr Debra Wujcik - Director of Cancer Clinical Trials, Meharry Medical College / The Vanderbilt-Ingram Cancer Center, USA )
7 May 2009
AACR 2009: MicroRNA profiles of colorectal adenocarcinomas
Dr Upender Manne - Associate Professor of Pathology, Birmingham School of Medici...
AACR 2009: MicroRNA profiles of colorectal adenocarcinomas ( Dr Upender Manne - Associate Professor of Pathology, Birmingham School of Medicine, University of Albama, USA )
7 May 2009
AACR 2009: Determinants of screening colonoscopy among african-american older ad...
Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School...
AACR 2009: Determinants of screening colonoscopy among african-american older adults ( Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, USA )
7 May 2009
AACR 2009: Identification of the EGFRvIII Mutation in Glioblastoma
Prof. Donald O'Rourke - Associate Professor of Neurosurgery, University of Penns...
AACR 2009: Identification of the EGFRvIII Mutation in Glioblastoma ( Prof. Donald O'Rourke - Associate Professor of Neurosurgery, University of Pennsylvania )
1 May 2009
AACR 2009: Genetics of pleuropulmonary blastoma
Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical C...
AACR 2009: Genetics of pleuropulmonary blastoma ( Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA )
1 May 2009
AACR 2009: Ovarian cancer biomarkers
Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospi...
AACR 2009: Ovarian cancer biomarkers ( Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA )
1 May 2009
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal canc...
Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Canc...
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer ( Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy )
1 May 2009
AACR 2009: Molecular profiling of tumours to find potential targets and treatmen...
Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. On...
AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers ( Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research )
1 May 2009
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strateg...
Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genen...
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer ( Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech )
30 Apr 2009
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL...
Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hosp...
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeu...
Dr Mamta Gupta - Mayo Clinic Cancer Center, USA
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer ( Dr Mamta Gupta - Mayo Clinic Cancer Center, USA )
30 Apr 2009
AACR 2009: DMC exerts antiangiogenic effects on the tumour vasculature
Professor Florence Hofman - Keck School of Medicine, University of Southern Cali...
AACR 2009: DMC exerts antiangiogenic effects on the tumour vasculature ( Professor Florence Hofman - Keck School of Medicine, University of Southern California )
30 Apr 2009
AACR 2009: Membrane microfilter device for capture and characterisation of circu...
Anthony Williams - Keck School of Medicine, University of Southern California
AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells ( Anthony Williams - Keck School of Medicine, University of Southern California )
30 Apr 2009
AACR 2009: DNA profiling for bladder cancer
Dr Gangning Liang - Associate Professor of Research, Department of Urology, Univ...
AACR 2009: DNA profiling for bladder cancer ( Dr Gangning Liang - Associate Professor of Research, Department of Urology, University of Southern California )
30 Apr 2009
AACR 2009: Genetic prostate cancer risk
Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA
AACR 2009: Genetic prostate cancer risk ( Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA )
30 Apr 2009
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia
Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medic...
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )
30 Apr 2009
AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian can...
Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Ander...
AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian cancer risk ( Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, USA )
30 Apr 2009
AACR 2009: Designer T-Cells tackle prostate cancer
Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston...
AACR 2009: Designer T-Cells tackle prostate cancer ( Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston University School of Medicine, USA )
30 Apr 2009